Metrovacesa S.A. (LON:0HXI)
London · Delayed Price · Currency is GBP · Price in EUR 9.04
-0.02 (-0.22%)
At close: Dec 23, 2025
Metrovacesa Market Cap
Metrovacesa has a market cap or net worth of 1.2 billion as of December 24, 2025. Its market cap has increased by 4.67% in one year.
Market Cap
1.20B
Enterprise Value
1.50B
Revenue
475.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
9.04
Market Cap Chart
Since February 6, 2018, Metrovacesa's market cap has decreased from 2.15B to 1.20B, a decrease of -44.19%. That is a compound annual growth rate of -7.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2025 | 1.20B | 9.33% |
| Dec 31, 2024 | 1.10B | 3.56% |
| Dec 29, 2023 | 1.06B | 24.08% |
| Dec 30, 2022 | 855.69M | -5.41% |
| Dec 30, 2021 | 904.60M | 10.38% |
| Dec 31, 2020 | 819.57M | -26.98% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 6, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 211.39B |
| HSBC Holdings | 200.13B |
| Shell | 154.91B |
| Unilever | 107.18B |
| Rio Tinto Group | 100.89B |
| Rolls-Royce Holdings | 96.68B |
| British American Tobacco p.l.c. | 91.68B |
| GSK plc | 72.63B |